J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. He takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity's core product RBM [...]
What SDV is really for? How it develops and to what form it evolves? What is the future role of a CRA? This article depicts a role of SDV in a clinical monitoring process, shows the path of [...]
A famous saying tells us that “experience often comes after one needs it”. Risk-based monitoring (RBM) is a major development and often fails in implementation due to its additional complexity and the variety of opinions of various stakeholders. In order to gain experience before one needs [...]
